Nosocomial Infections and Antibiotic Resistance: Prophylaxis and Treatment in the Surgical Setting Release Date: January 31, 2007
Nosocomial infection is a serious threat to millions of US inpatients yearly and carries a high rate of mortality (approximately 5%).
http://www.docmeonline.com/ce-bin/owa/pkg_disclaimer_html.display?ip_cookie=24257639&ip_mode=secure&ip_test_id=10917&ip_company_code=AOAMJAMA -- Antibiotic-Resistant "Superbugs" May Be Transmitted From Animals to Humans, November 14, 2007, Kuehn 298 (18): 2125.
2 recent epidemiological studies in distinct human populations suggest that bacteria are developing resistance to antibiotics on poultry farms and that these resistant bacteria are colonizing humans.
***********
Floroquinolones making resistance more likely
Link: HighWire Press -- Medline Abstract.
Our study underlines the need for infection control teams to focus efforts on preventing both MRSA- and MSSA-BSI. As recently demonstrated in vitro, fluoroquinolones may enhance horizontal transfer of virulent and antibiotic resistance genes. These antibiotics are widely used in France, so our findings raise the issue of whether their use has contributed to acquisition of mecA and tst genes by S. aureus strains.
Children becoming resistant to drugs they've never taken
Link: Journal Watch Infectious Diseases.
Worldwide, quinolone-resistance rates among gram-negative bacilli are rising rapidly. Widespread use of this class of antibiotics can cause selection of resistant organisms in the gut flora. Because these agents are rarely administered before age 18, children provide an opportunity to investigate the prevalence of quinolone-resistant gram-negative bacilli in individuals not exposed to quinolones. Investigators recently reported the results of stool screening among children without diarrhea who attended a general ambulatory pediatric office in Seattle between September 2001 and June 2002. Information on antibiotic use by the child and by other household members during the preceding 4 weeks was collected by questionnaire. Stools from 13 of 455 children (2.9%) grew gram-negative bacteria with high-level quinolone resistance (Escherichia coli, 7 children; Stenotrophomonas maltophilia, 4 children; Enterobacter aerogenes and Achromobacter xylosoxidans, 1 child each). Six of the 7 E. coli isolates were found to have additional extraintestinal virulence factors. Besides quinolone resistance, the 13 isolates showed varying resistance rates to other classes of antibiotics. None of the 13 children with resistant isolates had used a quinolone during the preceding 4 weeks, nor had members of their households. Use of other antibiotics by the children or their household members was not associated with detection of quinolone-resistant bacteria.
WHO | Antimicrobial resistance
http://www.who.int/mediacentre/factsheets/fs194/en/*************************************************************************
Florida Antibiotic Resistance Trends (One hospital) (2001-2005) (Gainesville)
METHODS: Antibiogram/sensitivity reports from a single medical center were incorporated into the database between 2001 and 2005. Data were reviewed for resistance trends for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus mirabilis, Streptococcus pneumoniae, Stapylococcal aureus, methicillin-resistant Staphyloccal aureus (MRSA), Enterococcus faecium, and Enterococcus sp.
RESULTS: For E.coli, increasing resistance was found for ampicillin, levofloxacin, ciprofloxacin, and piperacillin. All were consistent with national averages, except ampicillin which was slightly higher. For K. pneumoniae, ciprofloxacin and levofloxacin resistance trended higher, along with most cephalosporins; however, all rates were below national averages. For P. aeruginosa, an increasing trend was identified for ceftazidime and imipenem, but both rates were lower than national averages. For P. mirabilis, increased resistance was found for ampicillin, ciprofloxacin, and imipenem. Resistance rates for ciprofloxacin were higher than national averages. For S. aureus, increased resistance was seen with erythromycin, ciprofloxacin, levofloxacin, and oxacillin. Methicillin-resistant S. aureus (MRSA) rates were higher than national averages.
http://meeting.chestjournal.org/cgi/content/abstract/132/4/562***************************************************************************************************
U.S. Antibiotic Resistance Trends - children (2002-2004)
The overall resistance rates for females and males, respectively, were as follows:
ampicillin 44.3% and 44.6%; sulphamethoxazole/trimethoprim 24.5% and 36.7%; cefazolin 10.9% and 27.1%;
amoxicillin/clavulanic acid 12.4% and 27.5%; ciprofloxacin 0.9% and 2.4%; and nitrofurantoin 4.4% and 11.0%. Uropathogen resistance to commonly used antibiotics in the paediatric population was high.
************************************************************************************
Table 1. Methicillin resistance - Staph. Aureus bacteraemias, East of England 2001 – 2005 44%
http://www.hpa.org.uk/eastofengland/pdf/Antibiotic_Trends_bacteraemia.pdf*************************************************************
Wisconsin Antibiotic Resistance Campylobacter jejuni 2005
Tetracycline 53.7% ciprofloxacin 11% erythromycin 4.24% www.slh.wisc.edu/wps/wcm/connect/extranet/publications/campylobacter_jejuni_2005.php
*********
Children’s Urinary Tract Infection 2003
Resistance to cefotaxime sodium was 3% in the patients not receiving antibiotic prophylaxis, but was 27% in the children receiving prophylactic antibiotics. Resistance to aminoglycoside antibiotics was 1% in the children not receiving prophylaxis and 5% in the children receiving prophylactic antibiotics.
***********
Louisiana 2004 Table 1: Trend analysis of resistance for S. pneumoniae, S. aureus, Enterococcus species Louisiana, 2000-2004
DRSP, MRSA, VRE
2000 2001 2002 2003 2004 Z (C-A trend test) p-value
S Pneumoniae
% Resistant 42.87% 47.08% 44.05% 41.70% 43.34% -0.9648 0.3346
S. aureus
% Resistant 38.20% 44.46% 53.79% 56.67% 60.62% 42.4123 <.0001
Enterococcus
%Resistant 5.00% 4.95% 6.49% 6.08% 6.71% 6.3074 <.0001
******************
Texas Group B Streptococcus 2001 2004 whites twice as high as non-whites
Erythromycin 0 9%
Clindamycin 0 13%
E or C 0 19%
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1581469